Posted on 12/22/16
Bicycle Therapeutics is Named Winner of Fierce Innovation Award
CAMBRIDGE, U.K. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (BicycleTM) product platform, announced . . .
Posted on 12/21/16
CR Magazine Ladder Award Recognizes Cigna for Progress in Corporate Responsibility
BLOOMFIELD, Conn.--(BUSINESS WIRE)--Cigna (NYSE: CI), a global health service company, was named to the CR Magazine Ladder Award list as one of 25 companies that made . . .
Posted on 12/21/16
Akebia and Otsuka Pharmaceutical Announce Collaboration
CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ: AKBA) and Otsuka Pharmaceutical Co., Ltd. today announced they have entered into a collaboration and license agreement in . . .
Posted on 12/21/16
NeuroMetrix Announces $26.5 Million Public Offering
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (NASDAQ: NURO, NUROW) announced today the pricing of a public offering with expected gross proceeds from the offering of $26.5 million. The . . .
Posted on 12/21/16
Biogen’s Board of Directors Approves Separation of Bioverativ
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Inc. (NASDAQ: BIIB) today announced that its board of directors has approved the planned spin-off of its hemophilia business, which will be known . . .
Posted on 12/20/16
Surface Oncology Announces Collaboration with Dr. John Stagg
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Surface Oncology, an immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, announced today a CD73 antibody program, the next program in its . . .
Posted on 12/20/16
Hospira and Iatric Systems Partner
BOXFORD, Mass.--(BUSINESS WIRE)--Iatric Systems, Inc., a healthcare technology company dedicated to helping healthcare organizations enhance their IT investments, and Hospira, a Pfizer Company and leading provider . . .
Posted on 12/19/16
The Boston Globe names Ovia Health a Top Place to Work for 2016
Ovia Health, the leading women's digital health company behind the Ovia Fertility, Pregnancy, and Parenting apps, has been named one of the Top Places to Work . . .
Posted on 12/19/16
Better Buy: Juno Therapeutics vs. Alnylam Pharmaceuticals
These aren't the best of times for Juno Therapeutics (NASDAQ:JUNO) and Alnylam Pharmaceuticals (NASDAQ:ALNY). Both have experienced major clinical setbacks this year. Both biotechs have also . . .
Posted on 12/19/16
The 12 Greatest Medical Breakthroughs of 2016
IMAGE SOURCE: GETTY IMAGES.With less than two weeks to go before we turn the page on 2016, we can look back on another largely successful year . . .
Posted on 12/19/16
The Most Expensive Drugs of 2016
Prescription drug prices have gotten out of control for many Americans and many insurers. Some drugs cost as much as premium sports cars. Here are the . . .
Posted on 12/19/16
3 Low-Volatility Biotech Stocks to Buy
Are you hesitant to buy biotech stocks because of their volatility? If so, it's understandable. Many biotech stocks are very volatile, with frequent big swings up . . .
Posted on 12/18/16
RXi Pharmaceuticals Prices $10 Million Underwritten Public Offering
RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced the pricing of an underwritten public offering . . .
Posted on 12/16/16
Vericel Corp. Prices $17 Million Public Offering of Common Stock
CAMBRIDGE, Mass., Dec. 16, 2016 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious . . .
Posted on 12/16/16
Peak Physical Therapy & Sports Performance Names Ryan Burke as Physical Therapist in Hanover Location
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide
Posted on 12/16/16
Cancer Research UK and Bicycle Therapeutics Collaborate
LONDON & CAMBRIDGE, United Kingdom & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cancer Research UK, Cancer Research Technology (CRT), and Bicycle Therapeutics, a biotechnology company pioneering a new class of . . .
Posted on 12/16/16
Sunovion Announces Collaboration with AMDA
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) announced today a collaboration with AMDA – The Society for Post-Acute and Long-Term Care Medicine, the only medical specialty society . . .
Posted on 12/16/16
Wellness Workdays' CEO Invited to Present at 26th Annual Health Benefits Conference & Expo
Wellness Workdays, a leading provider of worksite wellness programs, announces its CEO Debra Wein will speak at the 26th Annual Health Benefits Conference & Expo (HBCE) in Clearwater Beach, . . .
Posted on 12/15/16
CVS Health Corporation's Biggest Mistake in 2016
Everyone makes mistakes -- even some of the biggest companies in the country. While CVS Health Corporation (NYSE:CVS) did plenty of things right in 2016, the . . .
Posted on 12/15/16
Hologic to Divest Blood Screening Business to Partner Grifols for $1.85 Billion
Hologic, Inc. (Nasdaq: HOLX) has entered into a definitive agreement to sell its share of its blood screening business to long-time commercial
Posted on 12/14/16
GI Dynamics Announces Completion of A$1.5 Million Private Placement
BOSTON & SYDNEY--(BUSINESS WIRE)--GI Dynamics®, (ASX:GID) a medical technology company that has developed an innovative device to improve outcomes for patients diagnosed with type 2 diabetes . . .
Posted on 12/14/16
Concert Pharmaceuticals Announces CTP-543 Positive Top-Line Phase 1 Results
LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced the Phase 1 single and multiple ascending dose trial evaluating CTP-543 in healthy volunteers has been completed. . . .
Posted on 12/14/16
Is the Worst Yet to Come for Alexion Pharmaceuticals?
It's usually not a good sign when a company's CEO suddenly departs. It's definitely not a good sign when both the CEO and CFO leave at . . .
Posted on 12/14/16
Better Buy: Intrexon Corporation vs. bluebird bio
IMAGE SOURCE: GETTY IMAGES.Although the word "biotech" is often used interchangeably with "biopharma," biology as technology is not confined to healthcare applications. That's the message engineered . . .
Posted on 12/14/16
Blueprint Medicines Closes Stock Offering
Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced the closing of its . . .
Boston
